Evidence map›Paper›PMID 10189846›Full record

ArticleGut1998

Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease.

A Cariappa, B Sands, D Forcione, D Finkelstein, D K Podolsky, S Pillai

Open access · bronzeAbstract read
In one paragraph

Article in Gut, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

A CariappaCancer Center, Massachusetts General Hospital, Boston, MA 02129, USA.
B Sands
D Forcione
D Finkelstein
D K Podolsky
S Pillai
Massachusetts General Hospital · USExecutive Office of the President · USHarvard University Press · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
MEMBRANE IMMUNOGLOBULIN ASSEMBLY AND FUNCTIONR01AI033507 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI PILLAI, SHIV SUBRAMANIAM · 1994 to 2002
$888k
NIAID NIH HHS AI-33507NIDDK NIH HHS P30DK43351
6 · The paper itself

Abstract

backgroundAlthough inflammation in Crohn's disease is believed to be mediated by activated T cells, genotyping of all MHC class II alleles in white people with this disease has not been reported.

aimsTo perform a detailed molecular analysis of HLA DPB, DQB, and DRB genes in white patients with Crohn's disease and controls in order to determine if the inheritance of any class II genes confers susceptibility or resistance to this disease.

methodsComplete molecular typing of HLA class II DPB, DQB, and DRB alleles was performed in 58 white patients with Crohn's disease and 93 healthy controls using a polymerase chain reaction-sequence specific oligonucleotide based approach.

resultsNo significant association with any DPB or DQB alleles was noted in patients with Crohn's disease. Since our previous studies had shown a strong association of an HLA DRB3*0301/DRB1*1302 haplotype with Crohn's disease, we re-examined this association using more stringent genotyping criteria. This haplotype was present in 20.7% of patients and 5.4% of controls (p = 0.0066; relative risk = 4.59).

conclusionsThe DRB3*0301/DRB1*1302 haplotype is the only significant MHC class II association noted in white people with Crohn's disease and represents the strongest association of any MHC or non-MHC locus with this disease.

Indexed as

AdultCrohn DiseaseGenes, MHC Class IIHLA-DP AntigensHLA-DP beta-ChainsHLA-DQ AntigensHLA-DQ beta-ChainsHLA-DR AntigensHLA-DRB1 ChainsHLA-DRB3 ChainsHumansPolymerase Chain ReactionWhite PeopleHLA-DP AntigensHLA-DPB1 antigenHLA-DP beta-ChainsHLA-DQ AntigensHLA-DQB1 antigenHLA-DQ beta-ChainsHLA-DR AntigensHLA-DRB1 ChainsHLA-DRB3 Chains

Identifiers

PMID10189846
PMCPMC1727213
OpenAlexW2128299917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.